High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers

By afschroeder • August 9, 2025

Ennin E, Mallepally N, Ali M, Shojaie L, Dewberry S, Trieu M, Torres ETR, Zhou K, Kahn J, Dodge JL, Dara L. High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver Int. 2025 Sep;45(9):e70255. doi: 10.1111/liv.70255. PMID: 40778804.

Tags: CTLA‐4, Digestive Diseases, Fellow, ILICI, immune‐related adverse events, immunotherapy, liver injury, PD‐1, Publications

Coccidioidal peritonitis: A rare manifestation of disseminated coccidioidomycosis

Cheung N, Harmon R, Dietz RL Jr, Chandna S, Shoucri S. Coccidioidal peritonitis: A rare manifestation of disseminated coccidioidomycosis. IDCases. 2026 Jul 5;45:e02674. doi: 10.1016/j.idcr.2026.e02674.[...]

Integrating Natural Language Processing With ChatGPT to Improve Quality of Artificial Intelligence Summaries of Prostate Cancer Consultations

Friedrich NA, Das SK, Luu M, Daniels JP, Heard J, Barsegyan A, Freedland SJ, Spiegel B, Kokorowski PK, Gonzalez Hernandez G, Daskivich TJ. Integrating Natural[...]

Frontier AI companies as biotech acquirers

Palermo A. Frontier AI companies as biotech acquirers. Nat Biotechnol. 2026 Jul 7. doi: 10.1038/s41587-026-03214-0. Epub ahead of print. PMID: 42414651.